Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
16.08
-0.50 (-3.02%)
At close: Aug 21, 2026

BOM:531015 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
186298149---
Market Cap Growth
22.17%99.78%----
Enterprise Value
180317153---
Last Close Price
16.0825.7728.52---

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
65.81120.26----
PS Ratio
2.003.7218.51---
PB Ratio
1.242.123.39---
P/TBV Ratio
1.242.123.39---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
1.943.9618.94---
EV/EBITDA Ratio
90.34263.64----
EV/EBIT Ratio
92.33272.70----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.010.020.01-0.54-0.49-0.37
Debt / EBITDA Ratio
1.062.75----
Debt / FCF Ratio
---160.04-0.18
Net Debt / Equity Ratio
-0.04-0.06-0.55-0.54-0.49-0.37
Net Debt / EBITDA Ratio
-3.06-7.412.34-3.34-1.89-2.74
Net Debt / FCF Ratio
0.050.081.06158.91-113.480.18
Asset Turnover
0.780.750.31---
Inventory Turnover
7.4813.79----
Quick Ratio
1.533.844.580.020.040.03
Current Ratio
9.237.956.780.020.150.12
Return on Equity (ROE)
3.38%2.68%-0.56%---
Return on Assets (ROA)
1.02%0.68%-24.94%-47.69%-56.94%-32.72%
Return on Invested Capital (ROIC)
1.30%1.37%-157.11%---
Return on Capital Employed (ROCE)
1.30%0.80%-23.70%17.30%27.30%14.60%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
1.76%0.83%-0.07%---
FCF Yield
-65.23%-36.84%-15.33%---
Buyback Yield / Dilution
-156.83%-125.60%----0.00%